| Literature DB >> 26616854 |
R Auvergne1,2, C Wu1,2, A Connell1,2, S Au1,2, A Cornwell1,2, M Osipovitch1,2, A Benraiss1,2, S Dangelmajer3, H Guerrero-Cazares3, A Quinones-Hinojosa3, S A Goldman1,2,4.
Abstract
Glioblastoma (GBM) remains the most common and lethal intracranial tumor. In a comparison of gene expression by A2B5-defined tumor-initiating progenitor cells (TPCs) to glial progenitor cells derived from normal adult human brain, we found that the F2R gene encoding PAR1 was differentially overexpressed by A2B5-sorted TPCs isolated from gliomas at all stages of malignant development. In this study, we asked if PAR1 is causally associated with glioma progression. Lentiviral knockdown of PAR1 inhibited the expansion and self-renewal of human GBM-derived A2B5(+) TPCs in vitro, while pharmacological inhibition of PAR 1 similarly slowed both the growth and migration of A2B5(+) TPCs in culture. In addition, PAR1 silencing potently suppressed tumor expansion in vivo, and significantly prolonged the survival of mice following intracranial transplantation of human TPCs. These data strongly suggest the importance of PAR1 to the self-renewal and tumorigenicity of A2B5-defined glioma TPCs; as such, the abrogation of PAR1-dependent signaling pathways may prove a promising strategy for gliomas.Entities:
Mesh：
Substances：
Year: 2015 PMID： 26616854 PMCID： PMC4885796 DOI： 10.1038/onc.2015.452
Source DB: PubMed Journal: Oncogene ISSN： 0950-9232 Impact factor: 9.867